90 filings
6-K
NYXH
Nyxoah SA
15 Apr 24
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
4:05pm
20-F
2023 FY
NYXH
Nyxoah SA
Annual report (foreign)
20 Mar 24
4:06pm
6-K
NYXH
Nyxoah SA
19 Mar 24
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
4:57pm
6-K
NYXH
Nyxoah SA
5 Mar 24
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
4:13pm
SC 13G/A
Together Partnership
14 Feb 24
Nyxoah / TOGETHER PARTNERSHIP ownership change
4:17pm
SC 13G/A
Taub Robert
14 Feb 24
Nyxoah / Taub Robert ownership change
4:17pm
6-K
NYXH
Nyxoah SA
17 Jan 24
Nyxoah Announces 2024 Strategic Priorities
4:12pm
6-K
NYXH
Nyxoah SA
9 Jan 24
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023
5:00pm
6-K
NYXH
Nyxoah SA
11 Dec 23
Current report (foreign)
4:05pm
6-K
NYXH
Nyxoah SA
8 Nov 23
Nyxoah Reports Third Quarter 2023 Financial and Operating Results
4:24pm
6-K
NYXH
Nyxoah SA
29 Sep 23
Nyxoah Announces Partnership with ResMed in Germany
4:05pm
6-K
NYXH
Nyxoah SA
8 Aug 23
Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results
5:56pm
6-K
NYXH
Nyxoah SA
28 Jul 23
Information on the total number of voting rights and shares
3:59pm
SC 13G/A
NYXH
Nyxoah SA
6 Jul 23
Nyxoah / RESMED ownership change
2:30pm
6-K
NYXH
Nyxoah SA
16 May 23
Nyxoah Reports First Quarter 2023 Financial and Operating Results
4:17pm
6-K
NYXH
Nyxoah SA
15 May 23
Current report (foreign)
4:07pm
6-K
NYXH
Nyxoah SA
11 May 23
Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer
4:05pm
6-K
NYXH
Nyxoah SA
20 Apr 23
Current report (foreign)
5:03pm
6-K
NYXH
Nyxoah SA
13 Apr 23
Current report (foreign)
4:09pm
SC 13G
NYXH
Nyxoah SA
6 Apr 23
Nyxoah / RESMED ownership change
4:42pm